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Perioral Acanthosis nigricansA
16.5-year-old girl with a history of perioral
hyperpigmented skin lesions presented for
evaluation. Her lesions were first recognized 4 years
earlier, and treated with topical cream. On examination,
she was obese (body mass index: 31.18 kg/m2, Z-score:
2.95), had symmetrical perioral hyperpigmented brownish
hyperkeratotic lesions extending to her chin (Figure, A),
and hyperpigmented lesions on her knuckles and neck. Her
laboratory examinations revealed homeostasis model
assessment-insulin resistance (Homa-IR): 6.17, high
triglyceride, and low high-density lipoprotein cholesterol
levels. Abdominal ultrasonography showed she had grade 2
hepatosteatosis. She thus fulfilled the metabolic syndrome
criteria. The lesions were diagnosed to be Acanthosis
nigricans associated with obesity and hyperinsulemia.1
Metformin was started with topical isotretimoin/
erythromycin gel along with weight loss recommendations.
One month later, she had lost 7 kg, her Homa-IR had
decreased to 2.37 and her perioral lesion completely
disappeared (Figure, B).
Acanthosis nigricans is the most common dermatologic
manifestations of obesity and insulin resistance. They are
symmetric, velvety, hyperpigmented plaques that can be
seen in almost any location but most commonly on the inter-
triginous areas of the axilla, groin, and posterior neck, the el-
bows, knuckles, and sometimes on face. It can be classified
into benign (obesity related, hereditary, and endocrine
forms) and malignant (associated with tumor) forms.2Figure. Perioral hyperpigmented brownish hyperkeratotic lesion
J Pediatr 2015;167:1453.
0022-3476/$ - see front matter. Copyright ª 2015 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.jpeds.2015.08.046Systemic therapies, oral retinoids (isotretinoin, acitretin),
can be effective. Metformin and rosiglitazone, along with a
low-calorie diet and increased physical activity, are useful
approaches.3 n
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